Share-based Payment Arrangement, Expense of Edesa Biotech, Inc. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Edesa Biotech, Inc. annual and quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • Edesa Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2025 was $200,000, a 100% increase year-over-year.
  • Edesa Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $700,000, a 40% increase from 2024.
  • Edesa Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $500,000, a 58% decline from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Edesa Biotech, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $700,000 +$200,000 +40% 01 Oct 2024 30 Sep 2025 10-K 12 Dec 2025 2025 FY
2024 $500,000 -$700,000 -58% 01 Oct 2023 30 Sep 2024 10-K 12 Dec 2025 2025 FY
2023 $1,200,000 01 Oct 2022 30 Sep 2023 10-K 13 Dec 2024 2024 FY

Edesa Biotech, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $200,000 +$100,000 +100% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q3
Q2 2024 $100,000 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.